col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: American Society of Hematology
  original article Journal Date Title Authors All Authors
1 [GO] Blood 2021―Oct―07 COVID-19 and VITT: same or different? Gowthami M. Arepally
2 [GO] Blood Advances 2021―Oct―06 Six Months Antibody Persistence after BNT162b2 mRNA COVID-19 Vaccination in Patients with Chronic Lymphocytic Leukemia Yair Herishanu, Irit Avivi, Shai Levi, Gabi Shefer, Yotam Bronstein, Miguel Morales Moshiashvili, et al. (+4)
3 [GO] Blood 2021―Sep―29 SARS-CoV-2 Vaccination and Immune Thrombocytopenia in de novo and pre-existing ITP patients Eun-Ju Lee, Marina Beltrami Moreira, Hanny Al-Samkari, Adam Cuker, Jennifer DiRaimo, Terry Gernsheimer, et al. (+13)
4 [GO] Blood 2021―Sep―29 Insights in ChAdOx1 nCov-19 Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT) Andreas Greinacher, Kathleen Selleng, Raghavendra Palankar, Jan Wesche, Stefan Handtke, Martina Wolff, et al. (+25)
5 [GO] Blood Advances 2021―Sep―28 Impact of sickle cell trait on morbidity and mortality from SARS-CoV-2 infection Lauren E. Merz, Kavita Mistry, Donna Neuberg, Revital Freedman, Gerda Menard, David M. Dorfman, et al. (+3)
6 [GO] Blood Advances 2021―Sep―20 Heparin-induced Thrombocytopenia in Patients with Coronavirus Disease 2019: Systematic Review and Meta-analysis Noppacharn Uaprasert, Nuanrat Tangcheewinsirikul, Ponlapat Rojnuckarin, Rushad Patell, Jeffrey I. Zwicker, Thita Chiasakul
7 [GO] Blood Advances 2021―Sep―16 Poor neutralizing antibody responses in 106 patients with WM after vaccination against SARS-CoV-2; a prospective study Maria Gavriatopoulou, Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Alexandros Briasoulis, Sentiljana Gumeni, Panagiotis Malandrakis, et al. (+8)
8 [GO] Blood 2021―Sep―06 COVID-19 as a potential trigger of complement-mediated atypical HUS. Carine El-Sissy, Antonin Saldman, Gilbert zanetta, Paula Vieira-Martins, Coralie Poulain, Raphaël Cauchois, et al. (+12)
9 [GO] Blood Advances 2021―Sep―02 American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate intensity anticoagulation in critically ill patients Adam Cuker, Eric K. Tseng, Robby Nieuwlaat, Pantep Angchaisuksiri, Clifton Blair, Kathryn Dane, et al. (+41)
10 [GO] Blood Advances 2021―Aug―13 Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma C. Perry, E. Luttwak, R. Balaban, G. Shefer, M. M. Morales, A. Aharon, et al. (+10)
11 [GO] Blood Advances 2021―Aug―13 Activity of mRNA COVID-19 vaccines in patients with lymphoid malignancies Jennifer L. Crombie, Amy C. Sherman, Chi-An Cheng, Christine E. Ryan, Rebecca Zon, Michaël Desjardins, et al. (+13)
12 [GO] Blood 2021―Aug―02 Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR-T cell therapy Binod Dhakal, Sameem M Abedin, Timothy S. Fenske, Saurabh Chhabra, Nathan Ledeboer, Parameswaran Hari, Mehdi Hamadani
13 [GO] Blood 2021―Jul―23 COVID-19 in patients with CLL: improved survival outcomes and update on management strategies Lindsey Elizabeth Roeker, Toby Andrew Eyre, Meghan C. Thompson, Nicole Lamanna, Alexander Coltoff, Matthew S. Davids, et al. (+45)
14 [GO] Blood 2021―Jul―23 Immune Thrombocytopenic Purpura after vaccination with COVID-19 Vaccine (ChAdOx1 nCov-19) Finn-Ole Paulsen, Christoph Schaefers, Florian Langer, Christian Frenzel, Ulrich Wenzel, Felicitas E. Hengel, et al. (+2)
15 [GO] Blood 2021―Jul―19 Anti-Platelet Factor 4 Antibodies Causing VITT do not Cross-React with SARS-CoV-2 Spike Protein Andreas Greinacher, Kathleen Selleng, Julia Mayerle, Raghavendra Palankar, Jan Wesche, Sven Reiche, et al. (+20)
16 [GO] Blood 2021―Jul―15 Thrombosis with COVID-19: kids get it too Cliff Takemoto
17 [GO] Blood Advances 2021―Jul―13 Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination Andrew Jay Portuguese, Cassandra Sunga, Rebecca Kruse-Jarres, Terry Gernsheimer, Janis Abkowitz
18 [GO] Blood 2021―Jul―01 Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell directed therapies Paola Ghione, Juan J Gu, Kristopher Attwood, Pallawi Torka, Shipra Goel, Suchitra Sundaram, et al. (+16)
19 [GO] Blood Advances 2021―Jul―01 Comorbidities are risk factors for hospitalization and serious COVID-19 illness in children and adults with sickle cell disease Lana Mucalo, Amanda M. Brandow, Mahua Dasgupta, Sadie F. Mason, Pippa M. Simpson, Ashima Singh, et al. (+4)
20 [GO] The Hematologist 2021―Jun―22 Masking, Vaccination, and Research Needed to Protect Our Most Vulnerable Against COVID-19 Jane N. Winter, Martin S. Tallman
21 [GO] The Hematologist 2021―Jun―22 What Is the Price of Preventing COVID-19 Infection? Rare Thrombotic/Thrombocytopenic Events Reported After Vaccination Damon E. Houghton, Anand Padmanabhan
22 [GO] Blood Advances 2021―Jun―17 A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2 Anne Louise Tølbøll Sørensen, Magalie Rolland, Jacob Hartmann, Zitta Barrella Harboe, Casper Roed, Tomas Ø. Jensen, et al. (+13)
23 [GO] Blood 2021―Jun―10 Efficacy of COVID-19 vaccine in patients with CLL
24 [GO] Blood 2021―Jun―10 Vaccination against COVID-19: a challenge in CLL Barbara Eichhorst
25 [GO] Blood 2021―Jun―02 SARS-CoV-2 infection induces the activation of tissue factor-mediated coagulation by activation of acid sphingomyelinase Jue Wang, Usha R. Pendurthi, Guohua Yi, L. Vijaya Mohan Rao
26 [GO] Blood 2021―May―20 Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry Dimitrios Giannis, Steven L. Allen, James Tsang, Sarah Flint, Tamir Pinhasov, Stephanie Williams, et al. (+22)
27 [GO] Blood 2021―May―14 Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2 Thomas Thiele, Lena Ulm, Silva Holtfreter, Linda Schönborn, Sven Olaf Kuhn, Christian Scheer, et al. (+7)
28 [GO] Blood 2021―May―05 COVID-19 Vaccines Induce Severe Hemolysis in Paroxysmal Nocturnal Hemoglobinuria Gloria Frances Gerber, Xuan Yuan, Jia Yu, Benjamin A.Y. Cher, Evan M. Braunstein, Shruti Chaturvedi, Robert A. Brodsky
29 [GO] Blood 2021―May―05 A Flow cytometric assay to detect platelet activating antibodies in VITT after ChAdOx1 nCov-19 vaccination Stefan Handtke, Martina Wolff, Carlo Zaninetti, Jan Wesche, Linda Schönborn, Konstanze Aurich, et al. (+5)
30 [GO] Blood 2021―Apr―28 Prothrombotic immune thrombocytopenia after COVID-19 vaccine Andreas Tiede, Ulrich J Sachs, Andreas Czwalinna, Sonja Werwitzke, Rolf Bikker, Joachim K Krauss, et al. (+6)
31 [GO] Blood 2021―Apr―25 Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C Hilary Baker Whitworth, Sarah E Sartain, Riten Kumar, Katherine Armstrong, Lance Ballester, Marisol Betensky, et al. (+14)
32 [GO] Blood 2021―Apr―17 Efficacy of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia Yair Herishanu, Irit Avivi, Anat Aharon, Gabi Shefer, Shai Levi, Yotam Bronstein, et al. (+7)
33 [GO] Blood 2021―Apr―17 Low Neutralizing Antibody Responses Against SARS-CoV-2 in Elderly Myeloma Patients After the First BNT162b2 Vaccine Dose Evangelos Terpos, Ioannis P Trougakos, Maria Gavriatopoulou, Ioannis Papassotiriou, Aimilia D Sklirou, Ioannis Ntanasis-Stathopoulos, et al. (+4)
34 [GO] Blood Advances 2021―Apr―01 COVID-19 in individuals with sickle cell disease/trait compared with other Black individuals Ashima Singh, Amanda M. Brandow, Julie A. Panepinto
35 [GO] Blood Advances 2021―Apr―01 Risk factors for seasonal human coronavirus lower respiratory tract infection after hematopoietic cell transplantation Chikara Ogimi, Hu Xie, Alpana Waghmare, Masumi Ueda Oshima, Kanwaldeep K. Mallhi, Keith R. Jerome, et al. (+3)
36 [GO] Blood 2021―Mar―18 Treon SP, Castillo JJ, Skarbnik AP, et al. The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients. Blood. 2020;135(21):1912-1915.
37 [GO] Blood Advances 2021―Mar―08 Heterogeneous NLRP3 inflammasome signature in circulating myeloid cells as a biomarker of COVID-19 severity Johan Courjon, Océane Dufies, Alexandre Robert, Laurent Bailly, Cédric Torre, David Chirio, et al. (+17)
38 [GO] Blood Advances 2021―Mar―03 The SARS-CoV-2 receptor-binding domain preferentially recognizes blood group A Shang-Chuen Wu, Connie M. Arthur, Jianmei Wang, Hans Verkerke, Cassandra D. Josephson, Daniel Kalman, et al. (+3)
39 [GO] Blood Advances 2021―Feb―26 A neutrophil activation signature predicts critical illness and mortality in COVID-19 Matthew L. Meizlish, Alexander B. Pine, Jason D. Bishai, George Goshua, Emily R. Nadelmann, Michael Simonov, et al. (+24)
40 [GO] Blood 2021―Feb―25 Another front in COVID-19’s perfect storm Shawn M. Jobe, Renren Wen
41 [GO] Blood Advances 2021―Feb―10 Kinase inhibitors developed for treatment of hematologic malignancies: implications for immune modulation in COVID-19 Chaja F. Jacobs, Eric Eldering, Arnon P. Kater
42 [GO] Blood Advances 2021―Feb―09 American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19 Adam Cuker, Eric K. Tseng, Robby Nieuwlaat, Pantep Angchaisuksiri, Clifton Blair, Kathryn Dane, et al. (+39)
43 [GO] Blood Advances 2021―Feb―09 COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experience Katie Maurer, Anna Saucier, Haesook T. Kim, Utkarsh Acharya, Clifton C. Mo, Julie Porter, et al. (+11)
44 [GO] Blood 2021―Feb―08 COVID-19 and Hematologic Malignancies: Single Institution Analysis Nwabundo Anusim, Melanie Smalley, Markie Sue Zimmer, Doyle Lang, Vishal Jindal, Hycienth O Ahaneku, et al. (+3)
45 [GO] Blood 2021―Feb―08 Association of Anticoagulant Use with COVID-19 Diagnosis Juraj Kavecansky, Jennifer R Dusendang, Jahan Tavakoli, Julie Schmittdiel, Gwendolyn Ho, Jodi Loyles, Ashok Pai
46 [GO] Blood 2021―Feb―08 Covid-19 Disease Is Not Associated with Venous Thromboembolism in a Cohort of Patients in Jeddah, Saudi Arabia Fatemah Kamel, Rania Magadmi, Sulafa Alqutub, Maha A. Badawi, Fatin Al-Sayes, Mazen Badawi, et al. (+2)
47 [GO] Blood 2021―Feb―08 Patient-Focused Benefits of at-Home Versus in-Clinic Administration of Cancer Therapy: New Considerations for the COVID-19 Era Karen E. Sandman, Timothy J. Bell
48 [GO] Blood 2021―Feb―08 Reduction in Transplantation Activity without Impairment in Outcomes in the Covid-19 Era- Data from the Sarah Cannon Blood Cancer Network (SCBCN) Minoo Battiwalla, Carlos Bachier, Vikas Bhushan, Michael J. Eckrich, Alireza Eghtedar, Haydar Frangoul, et al. (+11)
49 [GO] Blood 2021―Feb―08 Delivering Systemic Anti-Cancer Treatment Via Another Route of Administration As an Option to Reduce Exposure to COVID-19 in Patients with Multiple Myeloma in the UK Holly Cranmer, Tanja Podkonjak, Eugene Benson, Jonathon Dabora, Graham H Jackson
50 [GO] Blood 2021―Feb―08 ABO Blood Type and Outcomes in a Diverse COVID-19 Infected Population Sonal Paul, Nisha Patel, Chathula Kumarasinghe, Neil Nimkar, Angelica Singh, Nivetha Vishnuvardhan, et al. (+10)
51 [GO] Blood 2021―Feb―08 Association of Blood Type on Clinical Outcomes in Black/African Americans Hospitalized for COVID-19 Infection Yan Cheng, Sharif Mohammed, Alexis Okoh, Ki (Steve) Lee, Corinne Raczek, Amin Krushna, et al. (+2)
52 [GO] Blood 2021―Feb―08 Outcomes in Patients with Hematological Malignancies Receiving Anti-CD20 Therapy in the Setting of COVID-19 Infection Carlos A Lopez, David Chitty, Jeffrey Chi, Wasif Saif, Bradley Goldberg
53 [GO] Blood 2021―Feb―08 Outcomes of COVID-19 Infection in Patients with Hematologic Malignancies Elizabeth Behrens, Anne Timmermann, Alexander Yerkan, Deborah A. Katz, Agne Paner, Melissa C. Larson, et al. (+9)
54 [GO] Blood 2021―Feb―08 Prediction of COVID-19 Mortality in Patients with Cancer Simon Mantha, Justin Jee, Gerald A. Soff, Melissa S. Pessin
55 [GO] Blood 2021―Feb―08 Clinical Impact of COVID-19 on Anticoagulation Management at the William S. Middleton Memorial Veterans Hospital Hannah Hecht, Allison B Riendeau, Jillian Kolasinski, Cheryl Ray, Moniba Nazeef
56 [GO] Blood 2021―Feb―08 Increased Productivity and Efficiency Among Cancer Center Clinical Trials Workforce during the COVID-19 Pandemic Kimberly C Jenkins, Emily C Zabor, Lindsey A. R. Mooney, Aaron T. Gerds, Kerry O'Hop, Makenzie Guy, et al. (+3)
57 [GO] Blood 2021―Feb―08 A Shared Electronic Health Record in a Rural Setting Maintains Hematological Cancer Services Remotely during the COVID-19 Pandemic Helen Cashman, Eleni Mayson, David Kliman, Sue Vachalec, Jennifer Bell, Sam Milliken, et al. (+4)
58 [GO] Blood 2021―Feb―08 Utilization of Telemedicine for Comprehensive Visits in Patients with Inherited Bleeding Disorders during the COVID-19 Pandemic Cassandra P Wang, Kelly Ann Bush, Rosalie Brooks, Katharine Farrow, Lizandra Gilsdorf, Fernanda Cortez, Courtney D Thornburg
59 [GO] Blood 2021―Feb―08 Home Care Program for Managing Oncology Patients during COVID-19 Pandemic. a Tertiary Referral Center Experience Giamal Edin Gmati, Nadine Mabsut, Zainab Matar, Mona Alshami, Husam Shahata, Areej Alkhesaifi, et al. (+9)
60 [GO] Blood 2021―Feb―08 COVID-19 Pandemic Highlights Health Disparities in Latinos in San Diego Elisa Quiroz, David J Hermel, Samantha R Bagsic, Carrie L. Costantini, Anuj Mahindra, Alan Saven, et al. (+2)
61 [GO] Blood 2021―Feb―08 Older Age and Increased Neutrophil-to-Lymphocyte Ratio (NLR) Are Predictors of Mortality in a Multiethnic Urban Cohort of Hematologic Neoplasms and COVID-19 Patients Angelica D'Aiello, Sumaira Zareef, Kith Pradhan, Amanda Lombardo, Fariha Khatun, Jennat Mustafa, et al. (+39)
62 [GO] Blood 2021―Feb―08 Thrombotic Complications in COVID-19 Patients: Low Incidence of Thrombotic Complications Among Critically Ill COVID-19 Patients in Singapore Cheryl XQ Lim, Chuen Wen Tan, Bingwen Eugene Fan, Winnie Teo, Moon Ley Tung, Humaira Shafi, et al. (+21)
63 [GO] Blood 2021―Feb―08 COVID-19 Prognostic Score Utilizing Hematological and Inflammatory Markers to Determine Outcomes of Hospitalized Patients Amardeep Kalsi, Sana Irfan Khan, Asad Rehman, Neil Nimkar, Angelica Singh, Nivetha Vishnuvardhan, et al. (+11)
64 [GO] Blood 2021―Feb―08 Improvement in Clinic Efficiency, Patient Satisfaction, and Overcoming Unique Challenges in the Era of COVID-19 with Implementation of Subcutaneous Daratumumab in Patients with Multiple Myeloma (MM) and Light Chain (AL) Amyloidosis David Hughes, Radhika Jhaveri, Bhavesh Shah, Frances Blevins, Alexamil Rodriguez, Shayna Sarosiek, et al. (+3)
65 [GO] Blood 2021―Feb―08 Assessment of Hematologic and Coagulation Parameters As Predictive Value in COVID-19 with Unfavourable Evolution Viola Maria Popov, Lelia Iliescu, Marius Ioan Balea, Daniela Georgeta Georgescu, Mihaela Andreescu, Horia Bumbea, et al. (+21)
66 [GO] Blood 2021―Feb―08 Estimating Mortality in Patients with Hematological Malignancy and COVID-19: A Pooled Analysis of 10 Studies Kamal S. Saini, Marco Tagliamento, Matteo Lambertini, Richard McNally, Adrianne Kelly, Marco Romano, et al. (+5)
67 [GO] Blood 2021―Feb―08 Excellent Outcomes of Patients of Middle Eastern Ethnic Origin with Autologous Haemopoietic Stem Cell Transplantation and COVID-19: Does a Dampened Immune System Protect Against Severe COVID-19? Imran K Tailor, Syed Y Altaf, Nawal F Alshehry, Alaa M Alser, Mohammed Marei, Mansour Alfayez, et al. (+2)
68 [GO] Blood 2021―Feb―08 A Machine Learning Approach for the Differential Diagnosis between Sars-COV19 Infection and Influenza Viruses with Hematological Morphologic DATA (CELL MORPHOLOGIC DATA) Fernando Calvo Boyero, Sandra Gomez Gomez Rojas, Gloria Perez Segura, Ana Lopez Jimenez, Miguel Pedrera Jimenez, Gonzalo Carreño Gomez-Tarragona, et al. (+2)
69 [GO] Blood 2021―Feb―08 Prospective Pilot Study of Telehealth As Domiciliary Follow-up after Hematopoietic Cell Transplantation during the COVID19 Pandemic Alberto Mussetti, Maria Queralt Salas Gay, Maria Condom, Maite Antonio, Cristian Ochoa, Iulia Ivan, et al. (+6)
70 [GO] Blood 2021―Feb―08 Critical Care Support Improves Outcome of Haematology Admissions: A Retrospective Analysis during Covid Pandemic from UK Richard Whitmill, Supratik Basu, Anandadeep Mandal, Ubon Usung, Arwa Babai, Mustafa Mohamed
71 [GO] Blood 2021―Feb―08 Perception and Psychological Help Seeking Behaviour Among Hematology Healthcare Workers during the COVID19 Pandemic in India Lakshmi Prabha, Kishore Kumar
72 [GO] Blood 2021―Feb―08 COVID-19 Associated Coagulopathy: Thrombosis, Hemorrhage and Mortality Rates with an Escalated-Thromboprophylaxis Strategy Molly Daughety, Thomas L. Ortel, Erin Frost, Andrew Morgan, Chester Kao, Joyce Hwang, et al. (+2)
73 [GO] Blood 2021―Feb―08 Edoxaban Vs. Low Molecular Weight Heparin As Anticoagulant Therapy in Hospitalized Patients with Atrial Fibrillation and COVID-19 Infection Pável E Olivera, Desiree Campoy, César A Velasquez, Katia Flores, Tania Canals, Erik A Johansson, et al. (+4)
74 [GO] Blood 2021―Feb―08 Leveraging the Power of a Healthcare System to Fulfill the COVID Convalescent Plasma Needs Early in the COVID-19 Pandemic Valentina Baez Sosa, Cathy Conry-Cantilena, Glenn Wortmann, Emily R Fischer, Brandon G Clark, Lorraine Wyne, Aarthi Shenoy
75 [GO] Blood 2021―Feb―08 Clonal Hematopoiesis and COVID-19 Severity in Cancer Patients Kelly L. Bolton, Michael Foote, Justin Jee, Anton Safonov, Ryan Ptashkin, Sean Devlin, et al. (+13)
76 [GO] Blood 2021―Feb―08 Myelodysplastic Syndromes (MDS) & COVID-19: Clinical Experience from the US Epicenter of the Pandemic Jonathan Feld, Erin P. Demakos, Rosalie Odchimar-Reissig, Douglas Tremblay, Saudia Alli, Darshanie Sewah, et al. (+2)
77 [GO] Blood 2021―Feb―08 Prevalence of Sars-Cov-2 Infection in Patients with Chronic Myeloid Leukemia Simone Claudiani, Carolina Rosadas, Myra McClure, Maryam Khan, Richard S. Tedder, Andrew J. Innes, et al. (+2)
78 [GO] Blood 2021―Feb―08 COVID-19 in Patients with Lymphoma: A Grupo De Estudio Latinoamericano En Linfoproliferativos (GELL) Retrospective Study Guilherme Fleury Perini, Juan Alejandro Ospina Idarraga, Maria Alejandra Torres Viera, Brady E Beltran, Denisse A. Castro, Victoria Otero, et al. (+34)
79 [GO] Blood 2021―Feb―08 Incidence of Venous Thromboembolic Events in Hospitalized COVID-19 Patients: A Systematic Review Nicolas Galllastegui Crestani, Jenny Y Zhou, Annette von Drygalski, Timothy A Morris
80 [GO] Blood 2021―Feb―08 Sars-Cov-2 Spike Protein Induces Cellular Changes in Primitive and Mature Hematopoietic Cells James Ropa, Scott Cooper, Maegan L. Capitano, Hal E. Broxmeyer
81 [GO] Blood 2021―Feb―08 Impact of COVID19 Pandemic on an International MPN Patient Population: Survey Results from 1560 MPN Patients Jeanne M. Palmer, Carolyn Mead-Harvey, Claire Harrison, Amylou C. Dueck, Ryan Eckert, Heidi E. Kosiorek, et al. (+25)
82 [GO] Blood 2021―Feb―08 Outpatient Transplantation during the COVID19 Pandemic: Stretching the Limits for Continuing Care Perla R. Colunga Pedraza, Julia Esther Colunga Pedraza, Andres Gomez-De Leon, Mónica Bustillos Muñoz, Karen Lorena Osorno-Rodriguez, Jose Angel Hawing, et al. (+5)
83 [GO] Blood 2021―Feb―07 COVID-19 Infection in Patients with Paroxysmal Nocturnal Hemoglobinuria in Italy Wilma Barcellini, Bruno Fattizzo, Luisa Quattrocchi, Juri Alessandro Giannotta, Semra Aydin, Federica Barone, et al. (+6)
84 [GO] Blood 2021―Feb―07 Healthcare Utilization Among Children and Adolescents with Sickle Cell Disease during the COVID-19 Pandemic Andrea Nowlin, Kristina Lai, Alexander Maillis, Patricia Waters, Beatrice Gee, Peter A. Lane
85 [GO] Blood 2021―Feb―07 Venous Thromboembolism Prophylaxis Practices for Patients with Sickle Cell Disease Pre and during the COVID-19 Pandemic Jennifer G. Davila, W. Beau Mitchell, Kerry A Morrone, Ellen J Silver, Caterina P Minniti, Henny H. Billett, et al. (+3)
86 [GO] Blood 2021―Feb―07 COVID-19: B-Cell Depletion and Sepsis Related Changes in Bone Marrow and Spleen Jana Ihlow, Ann-Christin von-Bruenneck, Edward Georg Michaelis, Selina Greuel, Verena Heynol, Annika Lehmann, et al. (+9)
87 [GO] Blood 2021―Feb―07 Impact of Sickle Cell Trait on Morbidity and Mortality from Sars-Cov-2 Infection Lauren E. Merz, Kavita Mistry, Revital Freedman, Katherine L Jolley, Hae Soo Park, David M. Dorfman, et al. (+2)
88 [GO] Blood 2021―Feb―07 Thrombosis and Risk Management in Paediatric Inflammatory Multisystem Syndrome - Temporally Associated with Sars-CoV2 (PIMS-TS) Ho Pui Jeff Lam, Jayanthi Alamelu, James Brighouse, Owen Miller, Jonathan Lillie, Baba PD Inusa
89 [GO] Blood 2021―Feb―06 Evaluation of the Prothrombin Fragment 1.2 in Patients with COVID-19 Hanny Al-Samkari, Fei Song, Elizabeth M. Van Cott, David J. Kuter, Rachel P. Rosovsky
90 [GO] Blood 2021―Feb―06 Filter Clotting with Continuous Renal Replacement Therapy in COVID-19 Rachel P. Rosovsky, Paul Endres, Soophia H Zhao, Scott Krinsky, Shananssa G Percy, Omer Kamal, et al. (+13)
91 [GO] Blood 2021―Feb―06 Using Allogeneic, Off-the-Shelf, Sars-Cov-2-Specific T Cells to Treat High Risk Patients with COVID-19 Spyridoula Vasileiou, Manik Kuvalekar, Aster Workineh, Ayumi Watanabe, Yovana Velazquez, Suhasini Lulla, et al. (+7)
92 [GO] Blood 2021―Feb―06 Worldwide Examination of Patients with CLL Hospitalized for COVID-19 Lindsey E Roeker, Lydia Scarfo, Thomas Chatzikonstantinou, Pau Abrisqueta, Toby A. Eyre, Raul Cordoba, et al. (+147)
93 [GO] Blood 2021―Feb―06 Clinical Outcomes in Patients with Hematologic Malignancy (HM) and COVID-19 Michael Roderick Cook, Kaitlyn C Dykes, Katherine White, Jaeil Ahn, Nathan Cobb, Catherine Lai
94 [GO] Blood 2021―Feb―06 Severity of Sars-Cov-2 Infection in Patients with Hematologic Malignancies: A COVID-19 and Cancer Consortium (CCC19) Registry Analysis Samuel Rubinstein, Ryan C. Lynch, Aakash Desai, Catherine Stratton, Alokkumar Jha, Ziad Bakouny, et al. (+12)
95 [GO] Blood 2021―Feb―06 Clinical Course and Outcomes of Sickle Cell Disease Patients with COVID-19 at a New York Hospital Anita Mazloom, Neil Nimkar, Sonal Paul, Ayanna Baptiste
96 [GO] Blood 2021―Feb―06 COVID-19 in Patients (pts) with Chronic Myeloid Leukemia (CML): Results from the International CML Foundation (iCMLf) CML and COVID-19 (CANDID) Study Delphine Rea, Michael J. Mauro, Jorge E. Cortes, Qian Jiang, Katia B Pagnano, Matilda Ongondi, et al. (+4)
97 [GO] Blood 2021―Feb―06 Critical Telehealth and Healthcare Utilization during COVID-19 in Sickle Cell Disease: CBO Reach in Understanding the Patient Experience Jennifer Fields, Mary Brown, Chanell Grismore, Yadira Badwan, Susan Claster, Diane J. Nugent
98 [GO] Blood 2021―Feb―06 The Impact of COVID-19 on Hematology-Oncology Fellowship Programs: Program Director Perspectives Ana I. Velazquez Manana, Urshila Durani, Robby Reynolds, Ashok Kumbamu, Devika G. Das, Martina C. Murphy, et al. (+3)
99 [GO] Blood 2021―Feb―06 Impact on Mental Health, Disease Management and Socioeconomic Modifications in Hematological Patients during COVID-19 Pandemia in Italy Marianna De Muro, Sergio Amadori, Nicolina Rita Ardu, Elisabetta Cerchiara, Paolo De Fabritiis, Pasquale Niscola, et al. (+5)
100 [GO] Blood 2021―Feb―06 Drepadom - Home Care Services and Hospitalizations for Sickle Cell Disease Patients during the Covid-19 Pandemic Gonzalo De Luna, Nicolas Lemonier, Alexis Aidan, Lea Bontemps, Manuel Hautefaye, Hadrien Diakonoff, et al. (+7)
101 [GO] Blood 2021―Feb―06 Mental Health Assessment of Youth with Sickle Cell Disease and Their Primary Caretakers: Baseline Depression and COVID-19 Pandemic-Associated Psychosocial Stress in a Multi-Site Study Nancy S. Green, Deepa Manwani, Kim Smith-Whitley, Banu Aygun, Abena Appiah-Kubi, Arlene Smaldone
102 [GO] Blood 2021―Feb―06 Treating Acute Leukemia during the COVID-19 Pandemic: A Multicenter Latin American Registry Roberta Demichelis, Martha Alvarado, Jule F Vasquez, Nancy Delgado, Cynthia Gómez, Karla Adriana Espinosa, et al. (+26)
103 [GO] Blood 2021―Feb―06 Impact of Treatment and Anticoagulation on Thrombosis in COVID-19 Patients Surbhi Warrior, Elizabeth Behrens, Joshua Thomas, Priya Rajakumar, Sefer Gezer, Parameswaran Venugopal, Shivi Jain
104 [GO] Blood 2021―Feb―06 Increasing Doses of Anticoagulation Are Associated with Improved Survival in Hospitalized COVID-19 Patients Filip Ionescu, Girish B Nair, Ioana Petrescu, Anish S Konde, Markie Sue Zimmer, Nwabundo Anusim, et al. (+6)
105 [GO] Blood Advances 2021―Feb―06 Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge Fien A. von Meijenfeldt, Sebastian Havervall, Jelle Adelmeijer, Annika Lundström, Maria Magnusson, Nigel Mackman, et al. (+2)
106 [GO] Blood 2021―Feb―06 Hematologic Characteristics of Surviving Versus Non-Surviving COVID-19 Patients in Critical Care Units: Inner-City Hospital Experience, Detroit, MI Nino Balanchivadze, Raef Fadel, Jawad Sheqwara, Philip Kuriakose
107 [GO] Blood 2021―Feb―06 Admission Rothman Index, Aspirin, and Intermediate Dose Anticoagulation Effects on Outcomes in COVID-19: A Multi-Site Propensity Matched Analysis George Goshua, Yiwen Liu, Matthew L. Meizlish, Rebecca Fine, Kejal Amin, Eric Chang, et al. (+9)
108 [GO] Blood 2021―Feb―06 The Impact of ABO Blood Group on Clinical Outcomes and Susceptibility in COVID-19: A Retrospective Population Study of 3305 Patients Waleed Alduaij, Sarah Al-Youha, Ahmad Al-Serri, Sulaiman Almazeedi, Mohannad Al-Haddad, Mohammad H Jamal, Salman Al-Sabah
109 [GO] Blood 2021―Feb―06 Outcomes of Adult and Pediatric Patients with Hematologic Malignancies and COVID-19: A Systematic Review and Meta-Analysis of 1847 Patients Abi Vijenthira, Inna Gong, Thomas A Fox, Stephen Booth, Gordon Cook, Bruno Fattizzo, et al. (+13)
110 [GO] Blood 2021―Feb―06 Influenza Vaccination in Asplenia: Improving Quality of Care in Time of Coronavirus Nicoletta Di Maio, Giovanna Russo, Susanna Barella, Gian Luca Forni, Raffaella Colombatti, Lucia Notarangelo, et al. (+38)
111 [GO] Blood 2021―Feb―06 Leveraging Project Echo Telementoring to Improve Sickle Cell Disease Care in the Midwest: Expanding Provider Education during a Pandemic Lisa M Shook, Christina Bennett Farrell, Cami Mosley, Lori E Crosby, Charles T. Quinn
112 [GO] Blood Advances 2021―Feb―02 Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19 Erica Villa, Rosina Critelli, Simone Lasagni, Alessandra Melegari, Angela Curatolo, Ciro Celsa, et al. (+28)
113 [GO] Blood Advances 2021―Jan―29 Dissemination of extreme levels of extracellular vesicles: tissue factor activity in patients with severe COVID-19 Christophe Guervilly, Amandine Bonifay, Stephane Burtey, Florence Sabatier, Raphaël Cauchois, Evelyne Abdili, et al. (+10)
114 [GO] Blood Advances 2021―Jan―29 Platelet reactivity to thrombin differs between patients with COVID-19 and those with ARDS unrelated to COVID-19 Younes Zaid, Fadila Guessous, Florian Puhm, Wail Elhamdani, Lamyae Chentoufi, Andrew Conway Morris, et al. (+4)
115 [GO] Blood 2021―Jan―14 Vaccinations in CLL: implications for COVID-19 Mazyar Shadman, Chaitra Ujjani
116 [GO] Blood Advances 2021―Jan―13 Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection Caterina P. Minniti, Ahmar U. Zaidi, Mehdi Nouraie, Deepa Manwani, Gary D. Crouch, Andrew S. Crouch, et al. (+8)
117 [GO] Blood 2020―Dec―23 Antibody-induced procoagulant platelets in severe COVID-19 infection Karina Althaus, Irene Marini, Jan Zlamal, Lisann Pelzl, Anurag Singh, Helene Häberle, et al. (+11)
118 [GO] Blood 2020―Dec―19 Severe transient pancytopenia with dyserythropoiesis and dysmegakaryopoiesis in COVID-19-associated MIS-C Rachel Mariani, Huifei Liu
119 [GO] Blood 2020―Dec―19 Expanding the toolbox to combat a pandemic Susan E. Prockop
120 [GO] Blood Advances 2020―Dec―18 A toolkit for the collection of thrombosis-related data elements in COVID-19 clinical studies Deborah M. Siegal, Geoffrey D. Barnes, Nicole J. Langlois, Adrienne Lee, Saskia Middeldorp, Leslie Skeith, et al. (+2)
121 [GO] Blood Advances 2020―Dec―17 Incidence of symptomatic, image-confirmed venous thromboembolism following hospitalization for COVID-19 with 90-day follow-up Richard Salisbury, Valentina Iotchkova, Sarah Jaafar, Joshua Morton, Gavinda Sangha, Akshay Shah, et al. (+3)
122 [GO] Blood Advances 2020―Dec―09 Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations Caroline Diorio, Kevin O. McNerney, Michele Lambert, Michele Paessler, Elizabeth M. Anderson, Sarah E. Henrickson, et al. (+22)
123 [GO] Blood Advances 2020―Dec―05 Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub William A. Wood, Donna S. Neuberg, J. Colton Thompson, Martin S. Tallman, Mikkael A. Sekeres, Laurie H. Sehn, et al. (+8)
124 [GO] Blood Advances 2020―Dec―05 Challenges in treatment of patients with acute leukemia and COVID-19: a series of 12 patients Susanne Ghandili, Susanne Pfefferle, Kevin Roedl, Piet Sonnemann, Panagiotis Karagiannis, Olaf Boenisch, et al. (+11)
125 [GO] Blood 2020―Dec―03 COVID-19, plasma, and hypogammaglobulinemia Michael F. Murphy, Sunny Dzik
126 [GO] Blood 2020―Dec―03 Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset Josée Perreault, Tony Tremblay, Marie-Josée Fournier, Mathieu Drouin, Guillaume Beaudoin-Bussières, Jérémie Prévost, et al. (+4)
127 [GO] Blood 2020―Nov―17 How should we use convalescent plasma therapies for COVID-19? Erica Michelle Wood, Lise J Estcourt, Zoe McQuilten
128 [GO] Blood 2020―Nov―06 Clinical Features Associated with COVID-19 Outcome in MM: First Results from International Myeloma Society Dataset Ajai Chari, Mehmet Kemal Samur, Joaquin Martinez-Lopez, Gordon Cook, Noa Biran, Kwee L. Yong, et al. (+19)
129 [GO] Blood 2020―Nov―05 COVID-19-induced atypical pulmonary lymphocytes Véronique Vergé, Ranya Soufan
130 [GO] Blood 2020―Nov―04 Coagulation Dysfunction and Hematological Changes in 633 Patients with COVID-19 Mo Yang, Huixia Deng, Liuming Yang, Liang Li, Jieyu Ye, Yucai Cheng, et al. (+3)
131 [GO] Blood 2020―Nov―04 Thrombotic Complications in a Canadian Population of Critically Ill Patients with COVID-19 Simard Camille, Maral Koolian, Diana Escobar, Mark Blostein, Jed Lipes, Adelina Teona Avram, et al. (+4)
132 [GO] Blood 2020―Nov―04 Derivation and Validation of a Predictive Score for Disease Worsening Inpatients with COVID-19 Grigoris Gerotziafas, Patrick Van Dreden, Loula Papageorgiou, Theodoros N Sergentanis, Meletios-Athanasios Dimopoulos, Ismail Elalamy
133 [GO] Blood 2020―Nov―04 The Role of D-Dimer for Optimal Thromboprophylaxis Strategy in Patients with COVID-19 Lantarima Bhoopat, Anastasia Martynova, April Choi, Pattharawin Pattharanitima, Semi Han, Senxi Du, et al. (+5)
134 [GO] Blood 2020―Nov―04 Thrombosis and Mortality in Pregnant Patients with COVID-19 Elizabeth Behrens, Surbhi Warrior, Joshua Thomas, Xavier Pombar, Sefer Gezer, Parameswaran Venugopal, Shivi Jain
135 [GO] Blood 2020―Nov―04 COVID-19-Associated Coagulopathy: Safety and Efficacy of Prophylactic Anticoagulation Therapy in Hospitalized Adults with COVID-19 Isaac Chambers, Sanjana Dayal, Patrick Ten Eyck, Alicia Eustes, Grerk Sutamtewagul, Lori Rosenstein, et al. (+3)
136 [GO] Blood 2020―Nov―04 The Impact of Different Prophylactic Anticoagulation Doses on the Outcomes of Patients with COVID-19 Rodolfo Jiménez-Soto, Mercedes Aguilar-Soto, Roberta Demichelis
137 [GO] Blood 2020―Nov―04 Incidence of Vascular Thromboembolic Events in Outpatients with Mild COVID-19 Harish Eswaran, Jamie Jarmul, Amy Shaheen, David Meaux, Tristan Long, Derek Saccoccio, Stephan Moll
138 [GO] Blood 2020―Nov―04 Mild Anemia As a Single Independent Predictor of Mortality in Patients with COVID-19 Douglas Tremblay, Joseph Rapp, Naomi Alpert, William Lieberman-Cribbin, John Mascarenhas, Emanuela Taioli, Saghi Ghaffari
139 [GO] Blood 2020―Nov―04 Heparin Induced Thrombocytopenia in Patients with COVID-19 Surbhi Warrior, Elizabeth Behrens, Sefer Gezer, Parameswaran Venugopal, Shivi Jain
140 [GO] Blood 2020―Nov―04 Venous Thromboembolic Disease in Children Associated with COVID-19 Shalu Narang, Kavita Morparia, Prachi Sharma
141 [GO] Blood 2020―Nov―04 Immune Thrombocytopenia Associated with COVID-19 - Case Series Ramil Fatkhullin, Vasily Shuvaev
142 [GO] Blood 2020―Nov―04 Biomarkers of Hypercoagulability and Endothelial Cell Activation in Patients with Severe COVID-19 Admitted at the Intensive Care Unit. the Roadmap-COVID-19 Prospective Observational Study Patrick Van Dreden, Guillaume Voiriot, Alexandre Alabbadi, Ismail Elalamy, Loula Papageorgiou, Hélène Cost, et al. (+4)
143 [GO] Blood 2020―Nov―04 Risk Factors for Severe Form of COVID-19 after Allogeneic Hematopoietic Stem Cell Transplantation: A SFGM-TC Multicentre Cohort Study Alienor Xhaard, Constance Xhaard, Maud D'Aveni, Hélène Salvator, Marie-Laure Chabi-Charvillat, Tereza Coman, et al. (+13)
144 [GO] Blood 2020―Nov―04 Incidence of and Risk Factors for Venous Thromboembolism Among Hospitalized Patients with Cancer and COVID-19: Report from the COVID-19 and Cancer Consortium (CCC19) Registry Ang Li, Nicole M. Kuderer, Jeremy L. Warner, Aakash Desai, Dimpy P. Shah, Julie Fu, et al. (+25)
145 [GO] Blood 2020―Nov―04 Clinical Characterization and Risk Factors Associated with Cytokine Release Syndrome Induced By COVID-19 and Chimeric Antigen Receptor T-Cell Therapy Ruimin Hong, Houli Zhao, Yiyun Wang, Yu Chen, Hongliu Cai, Yongxian Hu, et al. (+2)
146 [GO] Blood 2020―Nov―04 COVID-19 and Stem Cell Transplantation; Results from the Prospective Survey By the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation (EBMT) and the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH) Per Ljungman, Rafael De La Camara, Malgorzata Mikulska, Gloria Tridello, Beatriz Aguado, Yves Beguin, et al. (+32)
147 [GO] Blood 2020―Nov―04 Circulating Histone Levels Correlate with the Severity of COVID-19 and the Extent of Coagulation Activation and Inflammation Rebecca Jane Shaw, James Austin, Joseph Taylor, Tina Dutt, Guozheng Wang, Simon Timothy Abrams, Cheng Hock Toh
148 [GO] Blood 2020―Nov―04 COVID-19 Associated Coagulopathy: A Comprehensive Assessment of the Coagulation Profile in Critically and Non-Critically Ill Patients Reyes María Martín-Rojas, Maite Chasco, Sara Casanova, Valeria Estefanía Delgado-Pinos, Gloria Perez-Rus, Patricia Duque, et al. (+3)
149 [GO] Blood 2020―Nov―04 Children and Young Adults Admitted to a NYC Children's Hospital Had a Similar Rate of Severe COVID-19 Coagulopathy As That Reported in Older Adults William Beau Mitchell, Jennifer G. Davila, Janine Keenan, Jenai Jackson, Adit Tal, Kerry A Morrone, et al. (+3)
150 [GO] Blood 2020―Nov―04 Newly Diagnosed Acute Lymphoblastic Leukemia in a Child with COVID-19 Complicated By MIS-C: A Case Report from Kuwait Fatemah Al-Haddad, Abdullah Ali, Danah Al-Sharrah, Suha Atyani, Hadeel Saleh, Ali M.A. Mullah-Ali
151 [GO] Blood 2020―Nov―04 COVID-19 Convalescent Plasma Decreased Oxygen Requirement and Hospital Stay in COVID-19 Hospitalized Patients Including Those with Hematological Malignancies: A Report of 16 Patients Moayed Ibrahim, Priya Pal, Alex Niu, Kevin Zwezdaryk, Elise Tatje, Leta Ko, et al. (+19)
152 [GO] Blood 2020―Nov―04 Whimsical (Waldenstrom's Macroglobulinemia Study Involving CArt-wheeL): A Global Patient-Derived Data Registry Capturing Treatment, Quality of Life and COVID-19 Data Ibrahim Tohidi-Esfahani, Andrew Warden, Elena Malunis, Peter Liburdi deNardis, Javier Haurat, Marita Black, et al. (+9)
153 [GO] Blood 2020―Nov―04 Prevalence of Low Limb Venous Thromboembolic Events in Mild and Severe/Critically Ill Patients with COVID-19 Despite Pharmacological Thromboprophylaxis Cong Zhang, Jialan Shi, Changjun WU, Chunxu Wang, Xinyi Zhao, Jinming Zhang, et al. (+9)
154 [GO] Blood 2020―Nov―04 The ACE2 Receptor for COVID-19 Entry Is Expressed on the Surface of Hematopoietic Stem/Progenitor Cells and Endothelial Progenitors As Well As Their Precursor Cells and Becomes Activated in Nlrp3 Inflammasome-Dependent Manner By Virus Spike Protein - a Potential Pathway Leading to a "Cytokine Storm" Magdalena Kucia, Kamila Bujko, Andrzej Ciechanowicz, Monika Cymer, Katarzyna Sielatycka, Janina Ratajczak, Mariusz Z Ratajczak
155 [GO] Blood 2020―Nov―04 COVID-19 Impact on Lymphoma Patients' Clinical Outcomes - an Observational Cohort Study Andrew Ip, Anthony Mato, Jordan Intrator, Nicholas P Howard, Alessandra Petrillo, Rosalba Vicioso, et al. (+6)
156 [GO] Blood 2020―Nov―04 COVID-19 in Chronic Myeloid Leukemia Patients - Brazilian Experience Katia B Pagnano, Ana Carolina Mourão Toreli, Leila Martins Perobelli, Acy TS Quixada, Fernanda S Seguro, Israel Bendit, et al. (+19)
157 [GO] Blood 2020―Nov―04 Clinical Characteristics and Outcomes of COVID-19 in HSCT Recipients Clarisse MARTINS Machado, Mariana Nassif Kerbauy, Iago Colturato, Leonardo Javier Arcuri, Ana Cláudia Ferrari dos Santos, Fernanda Rodrigues Silva, et al. (+5)
158 [GO] Blood 2020―Nov―04 COVID-19 in Patients with Hematologic Malignancies: A Single-Center Experience Lindsay Wilde, Adam F. Binder, Matthew Carabasi, Joanne Filicko-O'Hara, John L. Wagner, Onder Alpdogan, et al. (+12)
159 [GO] Blood 2020―Nov―04 COVID-19 in Patients with Hematological Malignancies: High False Negative Rate with High Mortality Alex Niu, Bo Ning, Francisco Socola, Hana Safah, Tim Reynolds, Moayed Ibrahim, et al. (+6)
160 [GO] Blood 2020―Nov―04 COVID-19 in Relation to Hematological Events (Thrombosis/Bleeding) and Mortality in Inpatient Setting Saikrishna Gadde, Nikhil Manjunath, Ambuga Badari, John T. Cole, Rula Saeed
161 [GO] Blood 2020―Nov―04 Outcomes in Patients with Hematologic Disease and COVID-19 in Russia: Interim Analysis of CHRONOS19 Registry Olga A. Gavrilina, Kristina Zakurdaeva, Vladimir I. Vorobyev, Anastasia N. Vasileva, Lev S. Butaev, Alena Sukhareva, et al. (+15)
162 [GO] Blood 2020―Nov―04 Hepatobiliary Manifistations of COVID-19 in Sickle Cell Disease: A Case Report Badria M. Alghamdi, Ohoud F. Kashari
163 [GO] Blood 2020―Nov―04 Frequency, Clinical Characteristics and Outcome of Adult Patients with Acute Lymphoblastic Leukemia (ALL) and COVID-19 in Spain: Results of a Survey from Pethema and Geth Groups Josep-Maria Ribera, Mireia Morgades, Rosa Coll, Jose Luis Lopez Lorenzo, Pau Montesinos, Rosario Varela, et al. (+15)
164 [GO] Blood 2020―Nov―04 Hospitalization and Case Fatality in Individuals with Sickle Cell Disease and COVID-19 Infection Lana Mucalo, Amanda M. Brandow, Sadie F. Mason, Ashima Singh, Bradley W. Taylor, Katherine J. Woods, et al. (+2)
165 [GO] Blood 2020―Nov―04 Elderly Hemopoietic and Inflammatory Signature for Life-Threatening COVID-19 Infection Jesus Romero, Jorge Mazzini, Sarvari Venkata Yellapragada, Iberia R. Sosa, Gustavo A. Rivero
166 [GO] Blood 2020―Nov―04 Autoimmune Hemolytic Anemia As Initial Presentation of COVID-19 Infection Gregorio Campos-Cabrera, Esther Mendez-Garcia, Maria Mora-Torres, Salvador Campos-Cabrera, Virgina Campos-Cabrera, Gabriel Garcia-Rubio, Jose-Luis Campos-Villagomez
167 [GO] Blood 2020―Nov―04 Atypical Presentation of COVID-19 Infection Cory Mellon, Salma Ferouz, Tariq Mubarak, Isoken Koko
168 [GO] Blood 2020―Nov―04 Evaluation of Soluble Fibrin Monomer Complex in Patients with Sars-Cov-2 COVID-19 Infection Meera Sridharan, Aneel A. Ashrani, Dong Chen, Nahla M. Heikal, Ariela L. Marshall, Rajiv K. Pruthi
169 [GO] Blood 2020―Nov―04 Low Rate of Thrombosis in Mexican Patients with COVID-19 Infection. a Benefit of Higher Doses Anticoagulants or a Sub Diagnosis? Félix Gibrant Marquez, Santiago Riviello-Goya, Angel Gabriel Vargas Ruiz, Edgar Ortíz Brizuela, Fernando Gil López, Alfredo Gutierrez Marín, et al. (+4)
170 [GO] Blood 2020―Nov―04 Outcomes of COVID-19 Infection in Patients Receiving Ruxolitinib and Hypomethylating Agent Therapy Daniel I. Nathan, Douglas Tremblay, Santiago Thibaud, John Mascarenhas, Janice L. Gabrilove
171 [GO] Blood 2020―Nov―04 ABO/Rh Blood Group and COVID-19 Infection Severity David J Hermel, Elisa Quiroz, Samantha R Bagsic, Carrie L. Costantini, Alan Saven, James R. Mason, et al. (+3)
172 [GO] Blood 2020―Nov―04 Outcomes of Patients with Hematologic Malignancies and COVID-19 Infection: A Report from the ASH Research Collaborative Data Hub William A. Wood, Donna S. Neuberg, John Colton Thompson, Martin S. Tallman, Mikkael A. Sekeres, Laurie H. Sehn, et al. (+8)
173 [GO] Blood 2020―Nov―04 Outcomes of Sickle Cell Disorders in COVID-19 Infection: An Institutional Experience Sarah Sewaralthahab, Hedy Smith
174 [GO] Blood 2020―Nov―04 Sickle Cell Disease Related Outcomes in Patients Evaluated for COVID-19 Infections in South Carolina Laurence Noisette, Mamatha Mandava, Mathew Gregoski, Shayla Bergmann
175 [GO] Blood 2020―Nov―04 The Elevation of LIVER Enzymes in Patients with Atrial Fibrillation and COVID-19 Is a Marker of Bad Evolution and Mortality Juan Jose Cerezo Manchado, Pável E Olivera, María Dolores Lopez Abellan, Desiree Campoy Castaño, César A Velasquez, Carlos Rodriguez Rojas, et al. (+7)
176 [GO] Blood 2020―Nov―04 Measuring the Impact of COVID-19 on Hematology-Oncology Trainees: A Quantitative and Qualitative Assessment Urshila Durani, Ana I. Velazquez Manana, Jori May, Marquita Nelson, Ze Zheng, Anurekha Gollapudi, et al. (+11)
177 [GO] Blood 2020―Nov―04 Impact of a National Lockdown for COVID-19 on Morbidity and Mortality Among Children with Sickle Cell Anaemia at a Tertiary Care Hospital in Uganda Ruth Namazzi, Robert Opoka, Andrea L Conroy, Dibyadyuti Datta, Micheal Goings, Chandy C. John
178 [GO] Blood 2020―Nov―04 COVID-19 Outcomes in Individuals with Sickle Cell Disease and Sickle Cell Trait Compared to Blacks without Sickle Cell Disease or Trait Ashima Singh, Amanda M. Brandow, Julie Panepinto
179 [GO] Blood 2020―Nov―04 Hematology Consultations during the COVID-19 Pandemic at a University Medical Center Daniel C Choi, Madhav Seshadri, Maria T De Sancho
180 [GO] Blood 2020―Nov―04 Analysis of Free-Text Responses in an International Myeloproliferative Neoplasms Patient Survey to Assess Impact of the COVID-19 Pandemic on Clinical Care Blake T. Langlais, Carolyn Mead-Harvey, Heidi E. Kosiorek, Gina L. Mazza, Ruben Mesa, Jeanne M. Palmer, Amylou C. Dueck
181 [GO] Blood 2020―Nov―04 A Survey of Survival Status of 601 Hemophilia Patients in Guangdong Region during COVID-19 Pandemic: Investigation and Implications Lei Meng, Jing Sun, Yufang Xun, Huiping Li, Zhuqin Liu, Xiaoqin Feng, Xuan Zhou
182 [GO] Blood 2020―Nov―04 The Challenge of Recruiting Convalescent Plasma Donors during the COVID-19 Pandemic: Preliminary Results from a Single Center in Midwest Brazil Maria do Rosario Ferraz Roberti, Tiago Paiva Prudente, Renato Gomes Castro, Marcos Antonio Candido, Roberta Luiza Rodrigues, Maria Cunha Ribeiro Morelli, et al. (+5)
183 [GO] Blood 2020―Nov―04 Efficacy of COVID-19 Pathogen Inactivated Convalescent Plasma for Patients with Moderate to Severe Acute COVID-19: A Case Matched Control Study Nina Khanna, Maja Weisser, Anemone Hedstueck, Sarah Tschudin Sutter, Sandra Roesch, Manuel Battegay, et al. (+15)
184 [GO] Blood 2020―Nov―04 A National Collaborative Multicenter Phase II Study for Potential Safety Efficacy of Convalescent Plasma to Treat Severe COVID-19 Patients Hani Al Hashmi, Deia Alawami, Syed Ziauddin A Zaidi, Nawal F Alshehry, Hazza A. Alzahrani, Abdul Rehman Z Zaidi, et al. (+15)
185 [GO] Blood 2020―Nov―04 Correlation between ABO Blood Groups and Disease Severity and Mortality in Hospitalized COVID-19 Patients Aula Ramo, Harshita Mehrotra, Ifeoma Onwubiko, Jawad Sheqwara, Zaher K. Otrock
186 [GO] Blood 2020―Nov―04 Anticoagulant and Antiplatelet Use Not Associated with Improvement in Severe Outcomes in COVID-19 Patients Gwendolyn Ho, Jennifer R Dusendang, Julie Schmittdiel, Juraj Kavecansky, Jahan Tavakoli, Ashok Pai
187 [GO] Blood 2020―Nov―04 Evaluation of Antiplatelet and Anticoagulation Therapy in High-Risk COVID-19 Patients Farah Ashraf, Anita Mazloom, Neil Nimkar, Nisha Patel, Amardeep Kalsi, Angelica Singh, et al. (+10)
188 [GO] Blood 2020―Nov―04 Hemorrhage Is a Major Cause of Blood Transfusion in COVID-19 Patients Cristina Sanz, Anabel Faundez, Anna García Carulla, Marta Rodriguez Aliberas, Anny Coromoto, Arturo Pereira
189 [GO] Blood 2020―Nov―04 Impact of Blood Group Type on Severity of Disease in COVID-19 Patients Shivani Rao, Surbhi Warrior, Sefer Gezer, Parameswaran Venugopal, Shivi Jain
190 [GO] Blood 2020―Nov―04 Thrombotic Microangiopathy Variants Are Independently Associated with Critical Disease in COVID-19 Patients Eleni Gavriilaki, Styliani Kokoris, Tasoula Touloumenidou, Evdoxia Koravou, Maria Koutra, Vassiliki Karali, et al. (+16)
191 [GO] Blood 2020―Nov―04 The Correlation between Absolute Lymphocyte Counts and Clinical Outcomes in COVID-19 Patients Mayer Goldberg, Madhumati Kalavar, Joseph Giovanetti
192 [GO] Blood 2020―Nov―04 Thrombocytopenia Associated with Increase in Disease Severity and Mortality in COVID-19 Patients Ranjit Banwait, Aya Marachi, Uma G. Iyer
193 [GO] Blood 2020―Nov―04 The Potential Role of Therapeutic Dose of Low Molecular Weight Heparin (LWMH) to Attenuate Hyper-Inflammatory State in Hospitalized COVID-19 Patients Mohsin Sheraz Mughal, Ikwinder Preet Kaur, Ali R. Jaffery, Chang Wang, Muhammad Asif, Anthony J. Ricca, et al. (+3)
194 [GO] Blood 2020―Nov―04 Extensive Characterization of the Hemostatic Derangement Occurring in COVID-19 Patients Admitted to the Bergamo Hospital Patricia Gomez-Rosas, Marina Marchetti, Eleonora Sanga, Sara Gamba, Cristina Verzeroli, Laura Russo, et al. (+7)
195 [GO] Blood 2020―Nov―04 Thrombotic Events in COVID-19 Patients and Its Comparison with Other Non-Sars-Cov-2 Respiratory Viruses Jing Yuan Tan, Chuen Wen Tan, Wan Hui Wong, Edwin Philip Conceicao, Ian Matthias Ng, May Anne Cheong, et al. (+3)
196 [GO] Blood 2020―Nov―04 Incidence of Thrombosis and Associated Risk Factors in Hospitalized COVID-19 Patients in a New York City Hospital System Poy P. Theprungsirikul, Sunil E. Saith
197 [GO] Blood 2020―Nov―04 Thromboembolic Outcomes of Hospitalized COVID-19 Patients in the 90-Day Post-Discharge Period: Early Data from the Northwell CORE-19 Registry Dimitrios Giannis, Steven L. Allen, Anne Davidson, Galina S. Marder, Sarah Flint, David Garrett, et al. (+8)
198 [GO] Blood 2020―Nov―04 Outcomes in COVID-19 Patients on Treatment Dose Anti-Coagulation Compared to Prophylactic Dose Anti-Coagulation Rich Kodama, Amardeep Kalsi, Angelica Singh, Nivetha Vishnuvardhan, Neil Nimkar, Sonal Paul, et al. (+10)
199 [GO] Blood 2020―Nov―04 Association between ROTEM Hypercoagulable Profile and Outcome in a Cohort of Severely Ill COVID-19 Patients Under Mechanical Ventilation Damian Ratano, Caragata Rebecca, Eddy Fan, Ewan C Goligher, Rita Selby, Niall D Ferguson, et al. (+2)
200 [GO] Blood 2020―Nov―04 Immunologic Characterization of Coronavirus Disease 2019 (COVID-19) Patients with Hematological Cancer: Biologic and Clinical Significance Catarina Maia, Esperanza Martín-Sánchez, Juan José Garcés, Ascensión López-Diaz de Cerio, Susana Inogés, Manuel Landecho, et al. (+16)
201 [GO] Blood 2020―Nov―04 Presentation, Management and Outcomes of COVID-19 Patients with Sickle Cell Disease Nwabundo Anusim, Ruby Gupta, Hycienth O Ahaneku, Candace Franklin, Savitha Balaraman, Marianne Terese Huben, Ishmael Jaiyesimi
202 [GO] Blood 2020―Nov―04 Use of Convalescent Plasma in COVID-19 Patients: Guayaquil, Ecuador Experience. Carlos Plaza, Brener Sabando, Yaira Loor Morán, Maria Alejandra Posligua, Luis Layedra, Jorge William Oliveros-Alvear
203 [GO] Blood 2020―Nov―04 Anticoagulation Management and Outcomes in Covid-19 Patients:a Multi-Center Retrospective Cohort Study Jasmeet Kaur, Anupam A Sule, Tracy Koehler, Geetha Krishnamoorthy, Jennifer DeLongpre
204 [GO] Blood 2020―Nov―04 Higher Tissue Factor (TF) Expression in the Lungs of COVID-19 Pneumonia Patients Than Patients with Acute Respiratory Distress Syndrome: Association with Thrombi Formation Sandeep Subrahmanian, Alain Borczuk, Steven P. Salvatore, Jeffrey Laurence, Jasimuddin Ahamed
205 [GO] Blood 2020―Nov―04 Clinical Trial to Evaluate an Approved ITP Therapy Targeting Spleen Tyrosine Kinase (SYK) for Prevention and Treatment of COVID-19 Related Complications Wolfgang Dummer, Vadim V. Markovtsov, Sandra Tong, Esteban Masuda
206 [GO] Blood 2020―Nov―04 Atypical Peripheral Blood Cell Morphology in COVID-19 (Sars-CoV-2) Patients from Mount Sinai Health System in New York City Christian Salib, Pallavi Khattar, Jinjun Cheng, Julie Teruya-Feldstein
207 [GO] Blood 2020―Nov―04 Does Thrombocytopenia Truly Correlate with COVID-19 Severity? Caroline Hana, Samar Aboulenain, Nakeya Dewaswala, Vijay Narendran
208 [GO] Blood 2020―Nov―04 Actions of L-Glutamine vs. COVID-19 Suggest Additional Benefit in Sickle Cell Disease Mahmoud A.Z. Abdelaal, Dyala Abdelrahman, Mahir Cengiz, Hakan Yavuzer, Serap Yavuzer, Ivy Bien, et al. (+9)
209 [GO] Blood 2020―Nov―04 Plasma Exchange for COVID-19 Thrombo-Inflammatory Disease Mari Thomas, Nishkantha Arulkumaran, David Brearley, Ferras Alwan, Deepak Singh, Michael P Lunn, et al. (+8)
210 [GO] Blood 2020―Nov―04 COVID-19 Thrombosis: Understanding the Negative Predictive Value in a Pandemic Talat Almukhtar, Julio Hajdenberg, Gurjot Garcha
211 [GO] Blood 2020―Nov―04 Serological Prevalence of Sars-Cov-2 Infection Among Chronic Myeloid Leukemia Patients Undergoing Tyrosine Kinase Inhibitor Treatment in Italy (COVID-19-HEM Study) Massimiliano Bonifacio, Gianni Binotto, Mario Tiribelli, Maria Cristina Miggiano, Malgorzata Monika Trawinska, Luigi Scaffidi, et al. (+14)
212 [GO] Blood 2020―Nov―04 Circulating Biomarkers of COVID-19-Triggered Endotheliopathy: From Conjecture to Certainty Ana Belen Moreno-Castaño, Sara Fernandez, Marta Palomo, Patricia Molina, Julia Martinez-Sanchez, Sergi Torramade-Moix, et al. (+12)
213 [GO] Blood 2020―Nov―04 Outcomes of Patients of Eastern Mediterranean Region with Lymphoma and COVID-19.Does Recent Chemo Immunotherapy Have a Role on Severity? Imran K Tailor, Nawal F Alshehry, Kamran Sabir, Abdul Rehman Z Zaidi, Mohammed Marei, Ibraheem Motabi, et al. (+3)
214 [GO] Blood 2020―Nov―04 CD28 Expression Distinguishes Plasma Cell Fate in Pediatric Patients Suffering from COVID-19/Kawasaki's Disease Vs MIS-C Adam Utley, Kelvin P. Lee, Mark Hicar
215 [GO] Blood 2020―Nov―04 VWF/ADAMTS13 Ratios Are Potential Markers of Immunothrombotic Complications in Patients with COVID-19: A Cross-Sectional Study Daria V Madeeva, Jana Christian, George Goshua, Hyung J. Chun, Alfred Ian Lee, Alexander B Pine
216 [GO] Blood 2020―Nov―04 Frequency of Venous Thromboembolism in 6513 Patients with COVID-19: A Retrospective Study Mark Crowther, David A. Garcia, Jason Hill, Bryan Savage, Shira Peress, Kevin Chang, Steven Deitelzweig
217 [GO] Blood 2020―Nov―04 Successful Outcomes of Children Simultaneously Diagnosed with Acute Myeloid Leukemia and Covid-19: The Role of a Mild Chemotherapeutic Induction Regimen Mecneide Mendes Lins, Juliana Teixeira Costa, Alayde Vieira Wanderley, Adriana Seber, Cinthya Rocha, Luciana Nunes Silva, et al. (+4)
218 [GO] Blood 2020―Nov―04 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Hematologic Patients: Experience at the Hospital Attending More Patients in Spain Alba Cabirta, Macarena Izuzquiza, Isabel Ruiz-Camps, David Valcarcel, Eva Catala, M Moraima Jimenez, et al. (+11)
219 [GO] Blood 2020―Nov―04 Use of Convalescent Plasma Therapy in Severe Coronavirus Disease 2019: The Yale-New Haven Health System Experience Sabrina L. Browning, Michael Gormally, Neima Briggs, Muyi Li, Alan Zakko, Maudry Laurent-Rolle, et al. (+11)
220 [GO] Blood 2020―Nov―04 Phase I and Preliminary Results of a Phase II Study (TERAPLASCoV2) of Convalescent Plasma in Patients with Severe and Life-Threatening Pneumonia Caused By Sars-Cov-2 Fernando Pérez-Jacobo, Luis Villela Villela, Edgar Velásquez-Vega, Jesús Hernández, Melani Otañez, Mónica Arellano-Mendoza, et al. (+23)
221 [GO] Blood 2020―Nov―04 Antibody Response Against Sars-Cov-2 in Convalescent Plasma Donors: Preliminary Results from a Single Center in Midwest Brazil Maria do Rosario Ferraz Roberti, Tiago Paiva Prudente, Renato Gomes Castro, Marcos Antonio Candido, Roberta Luiza Rodrigues, Francielle Barreto Machado Candido, et al. (+4)
222 [GO] Blood 2020―Nov―04 Longitudinal Serological Response to Sars-COV-2 in Patients Affected By Hematologic Diseases Chiara Cattaneo, Valeria Cancelli, Chiara Pagani, Alessandra Tucci, Giuseppe Rossi, Luisa Imberti, et al. (+6)
223 [GO] Blood 2020―Nov―04 Detailed Immunophenotypic Profiling of Peripheral Blood Immune Cells in Patients with Hematologic Malignancies after Sars-Cov-2 Infection Forat Lutfi, Jonathan Siglin, Gabriela Sanchez-Petitto, Ali Bukhari, David Gottlieb, Dong Won Kim, et al. (+8)
224 [GO] Blood 2020―Nov―04 Sars-Cov-2 Infection and Systemic Light Chain Amyloidosis: The International Society of Amyloidosis' Survey Paolo Milani, Vaishali Sanchorawala, Ramon Lecumberri, Sunil Saith, Mathew S. Maurer, M. Teresa Cibeira, et al. (+3)
225 [GO] Blood 2020―Nov―04 Impact of Sars-Cov-2 Infection in Acute Myeloid Leukemia Patients: Experience of the Pethema Registry Pilar Martínez, Tomás Palanques Pastor, Jose Luiz Lopez Lorenzo, Javier Cornago Navascués, Gabriela Rodriguez-Macías, Isabel Cano, et al. (+36)
226 [GO] Blood 2020―Nov―04 Impact of Sars-Cov-2 Infection in Hematopoietic Transplant Patients: Experience from the Madrid Group Rebeca Bailén, Mi Kwon, Beatriz Aguado, Rafael F. Duarte, Maria Calbacho, Anabelle Chinea, et al. (+12)
227 [GO] Blood 2020―Nov―04 Defibrotide for the Treatment of Endotheliitis Complicating Sars-Cov-2 Infection: Rationale and Ongoing Studies As Part of the International Defacovid Study Group Jose M. Moraleda, Carmelo Carlo-Stella, David Garcia-Bernal, Ruben Jara Rubio, Enriqueta Andreu, Eleonora Calabretta, et al. (+18)
228 [GO] Blood 2020―Nov―04 Inflammation Drives Coagulopathies in Sars-Cov-2 Patients Martha MS Sim, Meenakshi Banerjee, Melissa Hollifield, Hammodah Alfar, Xian Li, Alice Thornton, et al. (+9)
229 [GO] Blood 2020―Nov―04 Evidence of Microangiopathy in Children with Sars-Cov-2 Regardless of Clinical Presentation Caroline Diorio, Kevin O McNerney, Michele P. Lambert, Michele Paessler, Julie Chase, Kandace Gollomp, et al. (+18)
230 [GO] Blood 2020―Nov―04 Impaired Sars-Cov-2 Specific Antibody Responses in Patients Treated with Anti-CD20 Antibodies Alessandra Sottini, Luisa Imberti, Simone Paghera, Vanessa Previcini, Chiara Cattaneo, Eugenia Quiros-Roldan, et al. (+7)
231 [GO] Blood 2020―Nov―04 Environmental Sars-Cov-2 Surface Testing: Low Incidence of Virus Positivity in Outpatient and Inpatient Hematology/Oncology Settings Mansi R Shah, Imraan Jan, Jeremy Johns, Kuldip Singh, Pallavi Kumar, Norma Belarmino, et al. (+7)
232 [GO] Blood 2020―Nov―04 Real World Outcomes of Sars-Cov-2 Thrombosis Rates across Three University Health Systems in the Chicago Metropolitan Area Stephanie Berg, Seo-Hyun Kim, Sonam Patel, Priya Rajakumar, Elizabeth Jane Elliott, Candice Schwartz, et al. (+32)
233 [GO] Blood 2020―Nov―04 Analysis of Sars-Cov-2-Associated Proteins Identify Tank-Binding Kinase-1 As an Immunotherapeutic Target in Multiple Myeloma Arghya Ray, Ting DU, Krishan Chauhan, Yan Song, Dharminder Chauhan, Kenneth Anderson
234 [GO] Blood 2020―Nov―04 Outcomes in Patients with Hematologic Malignancies Infected with Sars-Cov-2: The Northwestern University Experience Carlos Galvez, Imran Nizamuddin, Emily Tuchman, Peter Doukas, Neha Reddy, Jessica K. Altman, et al. (+15)
235 [GO] Blood 2020―Nov―04 Impact of Sars-CoV2 Infection on 491 Hematological Patients: The Ecovidehe Multicenter Study Cristina De Ramón, Jose Angel Hernandez-Rivas, Jose Antonio Rodríguez García, Enrique M. Ocio, María Teresa Gómez-Casares, Javier López Jiménez, et al. (+13)
236 [GO] Blood 2020―Nov―04 How We Did Bone Marrow Transplants amidst the COVID19 Pandemic Kishore Kumar, Durai Prabhu, Dharani Devi, Dilshada Pulikkal, Joshua Daniel, Chezhian Subash
237 [GO] Blood 2020―Nov―04 Impact of the COVID19 Pandemic on Admissions and Emergency Department Visits of Adults with Sickle Cell Disease Alice J. Cohen
238 [GO] Blood 2020―Nov―04 Maximising Capacity and Saving Cost in an Outpatient Chemotherapy Centre during a Pandemic: A Quality Improvement Project Ednajoy Ngo, Cheng Ean Chee, Melinda Khoo, Yee Mei Lee, Belinda Tan, Yen-Lin Chee, Wei-Ying Jen
239 [GO] Blood 2020―Nov―04 Caring for Patients with Sickle Cell Disease during a Pandemic: Continuing to Provide Automated Red Blood Cell Exchange Transfusions in Difficult Times Richard Curtis Godby, Ashton Kornbrust, Denis Noubouossie, Jose Lima, Marisa B. Marques, Rance C Siniard
240 [GO] Blood 2020―Nov―04 Outcome of Severe Aplastic Anemia Treated with Low Dose Immunosuppression in Resource Limited World during Pandemic: Single Center Experience from Myanmar Aye Aye Gyi, Khin Thida Htut, Yin Nwe Han, Mie Mie Khine, Hnin Mya Thandar, Yi Mon Thant
241 [GO] Blood Advances 2020―Nov―02 Frequency of venous thromboembolism in 6513 patients with COVID-19: a retrospective study Jason B. Hill, David Garcia, Mark Crowther, Bryan Savage, Shira Peress, Kevin Chang, Steven Deitelzweig
242 [GO] Blood 2020―Oct―29 Targeting complement activation in COVID-19 Hrishikesh S. Kulkarni, John P. Atkinson
243 [GO] Blood 2020―Oct―28 Outcomes of patients with hematologic malignancies and COVID-19: A systematic review and meta-analysis of 3377 patients Abi Vijenthira, Inna Y. Gong, Thomas A Fox, Stephen Booth, Gordon Cook, Bruno Fattizzo, et al. (+13)
244 [GO] Blood 2020―Oct―26 SARS-CoV-2 specific T-cells Are Rapidly Expanded for Therapeutic Use and Target Conserved Regions of Membrane Protein Michael D. Keller, Katherine M. Harris, Mariah A. Jensen-Wachspress, Vaishnavi Kankate, Haili Lang, Christopher Andrew Lazarski, et al. (+27)
245 [GO] Blood Advances 2020―Oct―19 Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19 Mohammed Osman, Rehan M. Faridi, Wendy Sligl, Meer-Taher Shabani-Rad, Poonam Dharmani-Khan, Arabesque Parker, et al. (+5)
246 [GO] Blood Advances 2020―Oct―14 The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19 Ryan L. Hoiland, Nicholas A. Fergusson, Anish R. Mitra, Donald E. G. Griesdale, Dana V. Devine, Sophie Stukas, et al. (+8)
247 [GO] Blood Advances 2020―Oct―14 Reduced prevalence of SARS-CoV-2 infection in ABO blood group O Mike Bogetofte Barnkob, Anton Pottegård, Henrik Støvring, Thure Mors Haunstrup, Keld Homburg, Rune Larsen, et al. (+5)
248 [GO] Blood Advances 2020―Oct―08 Successful transfer of anti-SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19 Tim Luetkens, Ryan Metcalf, Vicente Planelles, Yue Zheng, Erin T. Larragoite, Emily S. Spivak, et al. (+11)
249 [GO] Blood 2020―Sep―22 Convalescent plasma therapy for B-cell depleted patients with protracted COVID-19 disease Thomas Hueso, Cécile Pouderoux, Hélène Péré, Anne-Lise Beaumont, Laure-Anne Raillon, Florence Ader, et al. (+31)
250 [GO] Blood Advances 2020―Sep―14 Successful management of SARS-CoV-2 acute respiratory distress syndrome and newly diagnosed acute lymphoblastic leukemia Lia Phillips, Jovana Pavisic, Dominder Kaur, N. Valerio Dorrello, Larisa Broglie, Nobuko Hijiya
251 [GO] Blood Advances 2020―Sep―11 COVID-19 convalescent plasma clears SARS-CoV-2 refractory to remdesivir in an infant with congenital heart disease Zahidee Rodriguez, Andi L. Shane, Hans Verkerke, Christopher Lough, Matthew G. Zimmerman, Mehul Suthar, et al. (+8)
252 [GO] Blood 2020―Sep―10 Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19 Eugenio D. Hottz, Isaclaudia G. Azevedo-Quintanilha, Lohanna Palhinha, Lívia Teixeira, Ester A. Barreto, Camila R. R. Pão, et al. (+6)
253 [GO] Blood 2020―Sep―10 COVID-19 concerns aggregate around platelets Elisabeth M. Battinelli
254 [GO] Blood Advances 2020―Sep―04 Variable CD34+ recovery of cryopreserved allogeneic HPC products: transplant implications during the COVID-19 pandemic Duncan Purtill, Vicki Antonenas, Paul Chiappini, Daochen Tong, Elizabeth O’Flaherty, Ashish Bajel, et al. (+11)
255 [GO] Blood 2020―Sep―03 A NET-thrombosis axis in COVID-19 Andrés Hidalgo
256 [GO] Blood 2020―Sep―03 When CLL meets COVID-19 Emili Montserrat
257 [GO] The Hematologist 2020―Sep―03 ASH Members Respond to COVID-19 Challenges ASH Staff
258 [GO] The Hematologist 2020―Sep―03 The Challenge We Face: Sickle Cell Disease and the COVID-19 Pandemic Ahmar U. Zaidi
259 [GO] The Hematologist 2020―Sep―03 Convalescent Plasma for COVID-19: An Old Therapy for a Novel Pathogen David T. Teachey, Caroline Diorio
260 [GO] The Hematologist 2020―Sep―03 COVID-19: ASH's Response Draws on the Strength of Our Community Stephanie Lee
261 [GO] The Hematologist 2020―Sep―03 Unmasking the Immunopathological Characteristics of COVID-19: Monocytes Grow With the Flow and Lymphocytes Shelter in Place? Annette S. Kim
262 [GO] The Hematologist 2020―Sep―03 Hematologic Therapies Being Studied for Coronavirus: Capitalizing on Progress Laura C. Michaelis, Kathleen Monahan
263 [GO] Blood 2020―Sep―02 Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition Jia Yu, Xuan Yuan, Hang Chen, Shruti Chaturvedi, Evan M. Braunstein, Robert A. Brodsky
264 [GO] Blood 2020―Sep―01 No evidence of SARS-CoV-2 transfusion-transmission despite RNA detection in blood donors showing symptoms after donation Pierre Cappy, Daniel Candotti, Virginie Sauvage, Quentin Lucas, Laure Boizeau, Johanna Gomez, et al. (+6)
265 [GO] Blood Advances 2020―Aug―25 The management of venous thromboembolism in hospitalized patients with COVID-19 Alex C. Spyropoulos
266 [GO] Blood 2020―Aug―14 Leukoerythroblastosis and plasmacytoid lymphocytes in a child with SARS-CoV-2-associated multisystem inflammatory syndrome Won Sok Lee, Elizabeth Margolskee
267 [GO] Blood 2020―Aug―14 Ritonavir- and lopinavir-induced eryptosis in a SARS-CoV-2-infected patient Gregoire Stalder, Lorenzo Alberio
268 [GO] Blood 2020―Aug―07 Post-discharge thrombosis and hemorrhage in patients with COVID-19 Rushad Patell, Thomas Bogue, Anita G Koshy, Poorva Bindal, Mwanasha Merrill, William C Aird, et al. (+2)
269 [GO] Blood 2020―Aug―06 Convalescent plasma to treat COVID-19 Evan M. Bloch
270 [GO] Blood 2020―Aug―06 COVID-19 and the Coombs test Jeanne E. Hendrickson, Christopher A. Tormey
271 [GO] Blood 2020―Aug―03 Post-discharge venous thromboembolism following hospital admission with COVID-19 Lara N Roberts, Martin Brunel Whyte, Loizos Georgiou, Gerard Giron, Julia Czuprynska, Catherine Rea, et al. (+4)
272 [GO] Blood 2020―Jul―23 COVID-19 coagulopathy, thrombosis, and bleeding Noel C. Chan, Jeffrey I. Weitz
273 [GO] Blood 2020―Jul―20 Outcomes of COVID-19 in Patients with CLL: A Multicenter, International Experience Anthony R. Mato, Lindsey Elizabeth Roeker, Nicole Lamanna, John Allan, Lori Ann Leslie, John M. Pagel, et al. (+56)
274 [GO] Blood Advances 2020―Jul―01 Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy) Bruno Fattizzo, Juri Alessandro Giannotta, Wilma Barcellini, Maria Chiara Barbanti, Cristina Bucelli, Ramona Cassin, et al. (+25)
275 [GO] Blood 2020―Jun―29 Neutrophil Extracellular Traps (NETs) Contribute to Immunothrombosis in COVID-19 Acute Respiratory Distress Syndrome Elizabeth A Middleton, Xue-Yan He, Frederik Denorme, Robert A. Campbell, David Ng, Steven P. Salvatore, et al. (+18)
276 [GO] Blood Advances 2020―Jun―23 COVID-19 coagulopathy vs disseminated intravascular coagulation Marcel Levi
277 [GO] Blood 2020―Jun―23 Platelet Gene Expression and Function in COVID-19 Patients Bhanu Kanth Manne, Frederik Denorme, Elizabeth A Middleton, Irina Portier, Jesse W Rowley, Chris J. Stubben, et al. (+8)
278 [GO] Blood 2020―Jun―23 Improved Clinical Symptoms and Mortality on Severe/Critical COVID-19 Patients Utilizing Convalescent Plasma Transfusion Xinyi Xia, Kening Li, Lingxiang Wu, Zhihua Wang, Mengyan Zhu, Bin Huang, et al. (+19)
279 [GO] Blood 2020―Jun―19 Red cell bound antibodies and transfusion requirements in hospitalized patients with COVID-19 Alessandra Berzuini, Cristiana Bianco, Cinzia Paccapelo, Francesco Bertolini, Giuliana Gregato, Alessandra Cattaneo, et al. (+13)
280 [GO] Blood 2020―Jun―19 Use of Convalescent Plasma in Hospitalized Patients with Covid-19 - Case Series Livia Hegerova, Ted Gooley, Kelly A Sweerus, Cynthia L Maree, Neil Bailey, Megumi Bailey, et al. (+14)
281 [GO] Blood Advances 2020―Jun―19 A report of clustered COVID-19 in a hematology ward Yaohui Wu, Fang Liu, Yun Fang, Xuan Lu, Yingying Wu, Linghui Xia, Mei Hong
282 [GO] Blood 2020―Jun―19 CHRONIC LYMPHOCYTIC LEUKEMIA MANAGEMENT IN ITALY DURING THE COVID-19 PANDEMIC. A CAMPUS CLL REPORT Antonio Cuneo, Lydia Scarfo, Gianluigi Reda, Marzia Varettoni, Francesca Maria Quaglia, Monia Marchetti, et al. (+12)
283 [GO] Blood 2020―Jun―18 Combination dose-escalated hydroxyurea and transfusion: an approach to conserve blood during the COVID-19 pandemic Robert Sheppard Nickel, Stefanie Margulies, Brittany Frazer, Naomi L. C. Luban, Jennifer Webb
284 [GO] Blood 2020―Jun―18 Hemophagocytic lymphohistiocytosis in SARS-CoV-2 infection Klaas Dewaele, Rowan Claeys
285 [GO] Blood 2020―Jun―18 Morphological changes in a case of SARS-CoV-2 infection John R. Jones, Robin Ireland
286 [GO] Blood 2020―Jun―11 Hypersegmented granulocytes and COVID-19 infection Christian Salib, Julie Teruya-Feldstein
287 [GO] Blood 2020―Jun―03 House Calls for Stem Cell Transplants During the COVID-19 Pandemic. Anthony D Sung, Krista R. Nichols, Nelson J. Chao
288 [GO] Blood 2020―Jun―03 COVID and Coagulation: Bleeding and Thrombotic Manifestations of SARS-CoV2 Infection Hanny Al-Samkari, Rebecca S Karp Leaf, Walter H Dzik, Jonathan CT Carlson, Annemarie E Fogerty, Anem Waheed, et al. (+7)
289 [GO] Blood 2020―May―28 COVID-19 and SCA: an old friend comes to the rescue Enrico M. Novelli
290 [GO] Blood 2020―May―28 Impact of anticoagulation prior to COVID-19 infection: a propensity score-matched cohort study Douglas Tremblay, Maaike van Gerwen, Mathilda Alsen, Santiago Thibaud, Alaina Justine Kessler, Sangeetha Venugopal, et al. (+13)
291 [GO] Blood 2020―May―27 Tocilizumab not associated with increased infection risk after CAR T - Implications for COVID-19? Matthew J Frigault, Sarah Nikiforow, Michael Mansour, Zhen-Huan Hu, Mary M Horowitz, Marcie Riches, et al. (+5)
292 [GO] Blood 2020―Apr―27 COVID-19 and its implications for thrombosis and anticoagulation Jean Marie Connors, Jerrold H Levy
293 [GO] Blood 2020―Apr―17 The BTK-inhibitor ibrutinib may protect against pulmonary injury in COVID-19 infected patients Steven P Treon, Jorge Castillo, Alan P Skarbnik, Jacob D Soumerai, Irene M Ghobrial, Maria Luisa Guerrera, et al. (+2)
294 [GO] Blood 2020―Apr―13 Initiating adjunct low dose-hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic Michael R DeBaun
295 [GO] Blood 2020―Apr―10 ILROG Emergency Guidelines for Radiation Therapy of Hematological Malignancies During the COVID-19 Pandemic Joachim Yahalom, Bouthaina S. Dabaja, Umberto Ricardi, Andrea Ng, N. George Mikhaeel, Ivan Richter Vogelius, et al. (+4)
296 [GO] Blood Advances 2020―Apr―03 First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab Xuhan Zhang, Kaidi Song, Fei Tong, Mingming Fei, Hui Guo, Zhaohui Lu, et al. (+2)


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.015 sec